Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share By
Nano-Structures Mediated Co-Delivery of Therapeutic Agents for Glioblastoma Treatment: A Review Publisher Pubmed



Mujokoro B1 ; Adabi M2 ; Sadroddiny E3 ; Adabi M2 ; Khosravani M4
Authors

Source: Materials Science and Engineering C Published:2016


Abstract

Glioblastoma is a malignant brain tumor and leads to death in most patients. Chemotherapy is a common method for brain cancer in clinics. However, the recent advancements in the chemotherapy of brain tumors have not been efficient enough. With the advancement of nanotechnology, the used drugs can enhance chemotherapy efficiency and increase the access to brain cancers. Combination of therapeutic agents has been recently attracted great attention for glioblastoma chemotherapy. One of the early benefits of combination therapies is the high potential to provide synergistic effects and decrease adverse side effects associated with high doses of single anticancer drugs. Therefore, brain tumor treatments with combination drugs can be considered as a crucial approach for avoiding tumor growth. This review investigates current progress in nano-mediated co-delivery of therapeutic agents with focus on glioblastoma chemotherapy prognosis. © 2016 Elsevier B.V.
Related Docs
View other Related Docs
1. Nanoparticles: Novel Vehicles in Treatment of Glioblastoma, Biomedicine and Pharmacotherapy (2016)
2. A Concise Review on Cancer Treatment Methods and Delivery Systems, Journal of Drug Delivery Science and Technology (2019)
3. Combination and Co-Delivery of Methotrexate and Curcumin: Preparation and in Vitro Cytotoxic Investigation on Glioma Cells, Journal of Pharmaceutical Innovation (2020)
Experts (# of related papers)
View all Related Experts
Mahdi Adabi (4)
Masood Khosravani (4)
Other Related Docs
4. Therapeutic Potentials of Curcumin in the Treatment of Glioblstoma, European Journal of Medicinal Chemistry (2020)
5. Immunology Meets Bioengineering: Improving the Effectiveness of Glioblastoma Immunotherapy, Cancers (2022)
6. Nanobased Cns Delivery Systems, Nanobiomaterials: Applications in Drug Delivery (2018)
7. Paclitaxel/Methotrexate Co-Loaded Plga Nanoparticles in Glioblastoma Treatment: Formulation Development and in Vitro Antitumor Activity Evaluation, Life Sciences (2020)
8. Lipidomics-Driven Drug Discovery and Delivery Strategies in Glioblastoma, Biochimica et Biophysica Acta - Molecular Basis of Disease (2025)
9. Gold Coated Poly (Ε-Caprolactonediol) Based Polyurethane Nanofibers for Controlled Release of Temozolomide, Biomedicine and Pharmacotherapy (2017)
10. Exosomal Noncoding Rnas: Key Players in Glioblastoma Drug Resistance, Molecular and Cellular Biochemistry (2021)
11. An Update on Actively Targeted Liposomes in Advanced Drug Delivery to Glioma, International Journal of Pharmaceutics (2021)
12. Cediranib, a Pan-Inhibitor of Vascular Endothelial Growth Factor Receptors, Inhibits Proliferation and Enhances Therapeutic Sensitivity in Glioblastoma Cells, Life Sciences (2021)
13. Blockade of Vascular Endothelial Growth Factor Receptors by Tivozanib Has Potential Anti-Tumour Effects on Human Glioblastoma Cells, Scientific Reports (2017)
14. Polymeric Nanoparticles for Drug Delivery in Glioblastoma: State of the Art and Future Perspectives, Journal of Controlled Release (2022)
15. The Role of Kinase Signaling in Resistance to Bevacizumab Therapy for Glioblastoma Multiforme, Cancer Biotherapy and Radiopharmaceuticals (2019)
16. Smart Biomaterials to Enhance the Efficiency of Immunotherapy in Glioblastoma: State of the Art and Future Perspectives, Advanced Drug Delivery Reviews (2021)
17. Preparation of Curcumin-Loaded Plga Nanoparticles and Investigation of Its Cytotoxicity Effects on Human Glioblastoma U87mg Cells, Biointerface Research in Applied Chemistry (2019)
18. Quercetin and Glioma: Which Signaling Pathways Are Involved?, Current Molecular Pharmacology (2022)
19. Nimodipine-Loaded Pluronic® Block Copolymer Micelles: Preparation, Characterization, In-Vitro and In-Vivo Studies, Iranian Journal of Pharmaceutical Research (2016)
20. Recent Advances in Glioma Cancer Treatment: Conventional and Epigenetic Realms, Vaccines (2022)